Growth Metrics

BioNexus Gene Lab (BGLC) Long-Term Debt Repayments (2019 - 2020)

BioNexus Gene Lab recorded quarterly Long-Term Debt Repayments of -$7901.0 in Q1 2020, down 137.7% quarter-over-quarter from -$3324.0 in Q4 2019, and down 119.11% year-over-year from $41351.2 in Q2 2019.

BioNexus Gene Lab's Long-Term Debt Repayments history runs 2 years deep, the most recent figure standing at -$7901.0 for Q1 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Repayments (Qtr)
1 Linde 230.79 Bn 226.84 Bn 4.26 Bn 733.00 Mn
2 Chemical & Mining Co Of Chile 127.66 Bn 124.93 Bn 778.60 Mn -
3 Sherwin Williams 72.51 Bn 72.30 Bn 2.78 Bn 350.00 Mn
4 Ecolab 70.96 Bn 70.34 Bn 1.85 Bn -
5 Air Products & Chemicals 62.15 Bn 63.70 Bn 987.40 Mn 19.10 Mn
6 Ppg Industries 25.04 Bn 23.57 Bn 1.66 Bn 700.00 Mn
7 LyondellBasell Industries 21.62 Bn 21.73 Bn 701.00 Mn -
8 Albemarle 20.26 Bn 19.42 Bn 500.97 Mn 1.30 Bn
9 DuPont de Nemours 19.45 Bn 19.56 Bn 602.00 Mn -
10 BioNexus Gene Lab 5.34 Mn 1.38 Mn -790.00 -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2020 -7,901.00
Mar 31, 2020 -7,901.00
Dec 31, 2019 -3,324.00
Dec 31, 2019 -3,324.00
Mar 31, 2019 -3,606.00
Mar 31, 2019 -3,606.00